Trana Discovery Announces Availability of Staphylococcus aureus Drug Discovery Assay
New high-throughput screening assay exploits transfer RNA (tRNA) as a target for inhibition…
CARY, NC (June 27, 2011) – Trana Discovery, Inc., a drug discovery technology company, today announced the availability of a new High-Throughput Screening (HTS) assay capable of selectively identifying compounds that inhibit the reproduction of Staphylococcus aureus bacteria through a unique mechanism of action: the inhibition of the bacteria’s ability to ...
Continue Reading →
27
JUN
Trana Discovery’s HIV Assay Finds Compounds that Inhibit NNRTI and Multi-Drug Resistant HIV Viruses
New study indicates that tRNA-based drug discovery technology selects anti-HIV bioactive compounds possessing novel antiviral action…
CARY, NC (December 14, 2010) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced that a recent study sponsored by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, affirms that bioactive compounds selected ...
Continue Reading →
14
DEC
Trana Discovery Receives Federal Grants for Anti-HIV and Antibiotic Drug Discovery Assays
Trana Discovery Receives Federal Grants for Anti-HIV and Antibiotic Drug Discovery Assays
Assays based on inhibition of tRNA receive $375,000 in funding…
CARY, NC (November 22, 2010) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced that two of the Company’s drug discovery assays, the novel anti-HIV 201 HTS Drug Discovery Assay and the Staphylococcus aureus Antibiotic Drug Discovery ...
Continue Reading →
22
NOV
Trana Discovery Expands Scientific Advisory Board
Trana Discovery Expands Scientific Advisory Board
World-renowned experts will focus on prioritizing prime disease targets for future assay development and new applications of the unique drug discovery technology…
CARY, NC (March 16, 2010) – Trana Discovery, Inc., an anti-infective drug discovery technology company, today announced three new members of its Scientific Advisory Board. Joining chairperson Michael Ossi, MD are Karin Musier-Forsyth, Ph.D., Ohio Eminent Scholar, The Ohio State University; ...
Continue Reading →
16
MAR
Trana Discovery Begins Development of Rapid Diagnostic Platform
Trana Discovery Begins Development of Rapid Diagnostic Platform
Rapid diagnostics based on tRNA identification could change how caregivers diagnose serious infectious diseases and prescribe treatments
CARY, NC (February 16, 2010) – Trana Discovery, Inc., an anti-infective drug discovery technology company, today announced that it has begun proof of concept studies on a rapid diagnostic platform that could identify the presence of the vast majority of infection-causing bacteria ...
Continue Reading →
16
FEB
Trana Discovery Completes $720,000 Series A Investment Round
Trana Discovery Completes $720,000 Series A Investment Round
Recent investment and future licensing deals leads to self-funded status
CARY, NC (December 21, 2009) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced the completion of its Series A round of funding. To date, the company has raised $720,000 in angel funding to commercialize technology that helps to discover new drugs for the treatment ...
Continue Reading →
21
DEC
Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition
CARY, NC and BIRMINGHAM, Ala. (October 28, 2009) – Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract research organization conducting basic and applied preclinical drug research, today announced that ...
Continue Reading →
28
OCT
Trana Discovery Forms Scientific Advisory Board; Taps Pharmaceutical Industry Veteran Mike Ossi as Chairperson
Trana Discovery Forms Scientific Advisory Board; Taps Pharmaceutical Industry Veteran Mike Ossi as Chairperson
New advisory board to identify assay development opportunities for emerging and drug-resistant infectious diseases…
CARY, NC (June 15, 2009) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced the formation of a Scientific Advisory Board that will advise the company on the needs ...
Continue Reading →
15
JUN
Trana Discovery Featured on Radio in Vivo
Trana Discovery Featured on Radio in Vivo
Drug discovery technology company develops tools to find new treatments for serious infectious diseases…
CARY, NC (May 5, 2009) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced that the company was featured on Radio in Vivo. CEO Steve Peterson and CTO Dick Guenther discuss how the company is developing technology for the discovery of new drugs ...
Continue Reading →
5
MAY
Trana Discovery Taps Pharmaceutical Industry Veteran Frank Johnson to Lead Sales and Marketing
Trana Discovery Taps Pharmaceutical Industry Veteran Frank Johnson to Lead Sales and Marketing
Company develops tools to find new treatments for serious infectious diseases…

CARY, NC (February 25, 2009) – Trana Discovery, Inc., a drug discovery technology company, today announced that Frank Johnson, a 33-year veteran of the pharmaceutical industry, ...
Continue Reading →
25
FEB